GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now gaining a significant focus in therapeutic studies, largely due to its impressive impact on treating diseases such as second type diabetes and excess body fat. New trials have demonstrated that beyond glucose control, GLP-1 medications offer benefits for cardiovascular function and